Skip to main content
NYXH
NASDAQ Industrial Applications And Services

Nyxoah Q3 Revenue €9.2M; New Risk Factor Flags Nasdaq $1.00 Bid-Price Delisting Threat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.811
Mkt Cap
$82.592M
52W Low
$0.8
52W High
$5.92
52W Position info
1.4% above low
Off High info
86% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

NYXH is trading near its 52-week low of $0.8 (1.4% above the low).

Summary

Nyxoah reported Q3 2026 global net revenue of €9.2 million (up 19% sequentially, U.S. up 29%) and, in new supplemental risk factors, warned its shares could fall below Nasdaq's $1.00 minimum bid price and face delisting.


Key Events · Earnings and Guidance · NYXH

  • Nasdaq Bid-Price Delisting Risk Disclosed

    New supplemental risk factors state the shares must not close below $1.00 for 30 consecutive trading days; a deficiency letter could follow, with a possible 180-calendar day grace period and delisting absent a reverse share split, which would require shareholder approval. The stock trades at $0.811.

  • Q3 Revenue €9.2M, U.S. Up 29%

    Global net revenue was €9.2 million, 19% sequential growth, with U.S. net revenue of €6.7 million up 29% sequentially; gross margin was 63.1%.

  • Cash Falls to €77.1M

    Cash, cash equivalents and financial assets totaled €77.1 million at September 30, 2026, down from €97.8 million at June 30, 2026, against a Q3 operating loss of €21.9 million.

  • PMA Supplement Filed for CCC

    Nyxoah submitted a PMA supplement to the FDA to expand Genio's U.S. indication to Complete Concentric Collapse patients, supported by a 77.2% 12-month AHI responder rate in the ACCCESS study.


Analysis · NYXH · Industrial Applications And Services

Commercial traction is real: global net revenue of €9.2 million rose 19% sequentially, and U.S. revenue of €6.7 million climbed 29%. The more consequential item, however, sits in the supplemental risk factors. With the stock at $0.811, Nyxoah now explicitly warns that it can fall below Nasdaq's $1.00 minimum bid price; after 30 consecutive trading days that triggers a deficiency letter, a possible 180-day grace period, and delisting if a reverse split (requiring shareholder approval) is not implemented. A previously implicit listing worry has become a disclosed, dated risk. Cash of €77.1 million at September 30 is down from €97.8 million at June 30, so the runway is finite while the operating loss was still €21.9 million in the quarter. Offsets that could broaden the addressable U.S. market: the PMA supplement for Complete Concentric Collapse patients and the 11-13% CMS 2027 reimbursement increases.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NYXH was trading at $0.81 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $82.6M. The 52-week trading range was $0.80 to $5.92. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NYXH - Latest Insights

NYXH
Nov 18, 2026, 2:30 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.8999
Real-time Price: $0.805 info
Change: -$0.0949 (-11%) info
Market Cap: $81.981M info
NYXH
Oct 20, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $0.805 info
Change: -$0.135 (-14%) info
Market Cap: $81.981M info
NYXH
Sep 29, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.37
Real-time Price: $0.805 info
Change: -$0.565 (-41%) info
Market Cap: $81.981M info
NYXH
Jul 09, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $0.805 info
Change: -$0.865 (-52%) info
Market Cap: $81.981M info
NYXH
Jun 23, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $0.805 info
Change: -$0.765 (-49%) info
Market Cap: $81.981M info